This portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event. Archived information may be superseded by more recent information we have disclosed in later presentations, press releases, filings with the Securities and Exchange Commission or otherwise. Archived information may contain forward-looking statements. Actual results may materially differ based on several factors, including those described in the archived information, press releases and our filings with the SEC.
Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999
- December 27, 2006
Targacept to Receive $20 Million Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480 (TC-1734) - December 19, 2006
Targacept Begins Phase II Clinical Trial in Acute Post-Operative Pain - December 04, 2006
Targacept to Ring the NASDAQ Stock Market Closing Bell - November 29, 2006
Targacept to Host NNR Analyst Day in New York - November 21, 2006
Targacept to Present at Lazard and CIBC Investor Conferences - November 09, 2006
Targacept Reports Third Quarter 2006 Financial Results - November 09, 2006
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression - November 02, 2006
Targacept to Report Third Quarter Financial Results on November 9, 2006 - October 25, 2006
Targacept to Present at Upcoming Investor Conferences - October 24, 2006
Targacept Announces Addition of Alan W. Dunton, M.D. to Its Board of Directors - October 17, 2006
Targacept Presents Data at the 36th Annual Meeting of the Society for Neuroscience - August 30, 2006
Targacept to Present at Thomas Weisel Partners Healthcare Conference - August 09, 2006
Targacept Reports Second Quarter 2006 Financial Results - August 02, 2006
Targacept to Report Second Quarter 2006 Financial Results on August 9, 2006 - June 06, 2006
Targacept to Present at Pacific Growth Equities Life Sciences Growth Conference - May 25, 2006
Targacept Reports First Quarter 2006 Financial Results - May 19, 2006
Targacept to Report First Quarter 2006 Financial Results on May 25, 2006 - May 17, 2006
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects - May 16, 2006
Targacept Announces Upcoming Conference Participation - April 12, 2006
Targacept Announces Pricing of Its Initial Public Offering - February 06, 2006
Targacept Announces Early Completion of Hart-Scott-Rodino Waiting Period for Agreement with AstraZeneca - January 17, 2006
Targacept Files for Initial Public Offering